UDCA for Symptomatic Gallstone Disease
Cholecystolithiasis
About this trial
This is an interventional treatment trial for Cholecystolithiasis focused on measuring ursodeoxycholic acid, gallstone, complications, pancreatitis, gallbladder motility, colic
Eligibility Criteria
Inclusion Criteria: Patients between 18 and 75 years of age study are upon admission to the waiting list for elective cholecystectomy for symptomatic cholecystolithiasis defined as: presence of gallbladder stones or sludge, without bile duct stones or bile duct dilatation at ultrasonography;\ at least one episode of severe right upper quadrant or midline epigastric pain of at least 30 min. duration, with radiation and/or movement urge, or at least three episodes of severe right upper quadrant or midline epigastric pain of at least 30 min. duration without such radiation or movement urge, in the previous 12 months Exclusion Criteria: Contra-indication for general anaesthesia or surgery Current or previous acute cholecystitis, obstructive jaundice or pancreatitis Previous papillotomy, because of preferential flow of UDCA-enriched bile to the intestine rather than to the gallbladder Pregnancy or lactation Current or previous use of UDCA Participation in another study Inability to speak Dutch or English or mental disability
Sites / Locations
- UMC Utrecht